Globus Medical Preps IPO, Sales Force Ramp Ahead Of Artificial Cervical Disc Approval
This article was originally published in The Gray Sheet
Executive Summary
Firm files for initial public stock offering, awaits PMA approval of its Secure-C artificial cervical disc.
You may also be interested in...
Financings In Brief
Globus Medical goes public. Exact Sciences nets $57.8 million from stock sale for cancer test. Cleveland Heart gets $30 million for artificial heart development. More financings.
New Guidance Outlining Total Artificial Disc Trial Design Issued
Investigational device exemption applications for total artificial disc systems should include plans for product durability testing and multi-center clinical trials with at least two years of follow-up, according to new FDA guidance
Atlas Biomed Unlocking Japan’s OTC Market With Direct-To-Consumer DNA And Microbiome Tests
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: